Drug search by name

Bevacizumab-awwb Intravenous and Thromboembolic disorders

Result of checking the interaction of drug Bevacizumab-awwb Intravenous and disease Thromboembolic disorders for safety when used together.

Check result:

Bevacizumab-awwb Intravenous <> Thromboembolic disorders

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Venous and arterial thromboembolic events (VTE and ATE), some fatal, have been reported with the use of inhibitors of vascular endothelial growth factor receptors (VEGFR). Caution is recommended when using these agents in patients with a reported history of VTE or ATE. These agents should be discontinued in patients with serious or life-threatening VTE or ATE, including pulmonary embolism.

Bevacizumab-awwb Intravenous

Generic Name: bevacizumab

Brand Name: Avastin, Mvasi

Synonyms: Bevacizumab

What is Bevacizumab-awwb Intravenous?